Testing effectiveness (Phase 2)Study completedNCT03380026
What this trial is testing
Mechlorethamine Induced Contact Dermatitis Avoidance Study
Who this might be right for
Cutaneous T-cell LymphomaCutaneous T-cell Lymphoma Stage IMycosis Fungoides+5 more
Rochester Skin Lymphoma Medical Group, PLLC 28